Jul 26, 2024 / 12:00PM GMT
Operator
Good day and welcome to the Bristol Myers Squibb second quarter 2024 earnings conference call. (operator instructions) Please note, today's event is being recorded. I would now like to turn the conference over to Tim Power, Vice President, Head of Investor Relations. Please go ahead.
Timothy Power - Bristol-Myers Squibb Co - Investor Relation
Thank you, and good morning, everyone. Thanks for joining us this morning for our second quarter 2024 earnings call. Joining me this morning with prepared remarks are Chris Boerner are Board Chair and Chief Executive Officer; and David Elkins our Chief Financial Officer. Also participating in today's call, Adam Lenkowsky, our Chief Commercialization Officer, and Samit Hirawat, our Chief Medical Officer and Head of Global developments.
As you'll note, we've posted slides to bms.com that you can use to follow along with Chris and David's remarks.
Before we get started, I'll read our forward looking statements. During this call, we may make statements about the company's future plans and prospects constitute
Q2 2024 Bristol-Myers Squibb Co Earnings Call Transcript
Jul 26, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers